Gap Junction Protein, alpha 3, 46kDa (GJA3) (N-Term) Peptide
-
- Target See all GJA3 products
- GJA3 (Gap Junction Protein, alpha 3, 46kDa (GJA3))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-GJA3 antibody (Catalog #: ARP36626_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- GJA3 (Gap Junction Protein, alpha 3, 46kDa (GJA3))
- Background
-
GJA3 belongs to the connexin family. One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell. Defects in GJA3 are the cause of zonular pulverulent cataract type 3 (CZP3).
Alias Symbols: CX46, CZP3
Protein Interaction Partner: CAV1,GJA1,MIP,PRKCG,TJP1,GJA1,TJP1
Protein Size: 435 - Molecular Weight
- 47 kDa
- Gene ID
- 2700
- NCBI Accession
- NM_021954, NP_068773
- UniProt
- Q9Y6H8
-